Glycopyrrolate inhaled
SEEBRI
“Glad cops relate”
What it isInhaled long-acting muscarinic antagonist (LAMA) for COPD maintenance, alone or in fixed combinations.
Why this oneQuaternary ammonium structure keeps it out of the CNS, delivering bronchodilation with minimal systemic anticholinergic burden.
What limits itMaintenance, not rescue, and the usual antimuscarinic cautions (narrow-angle glaucoma, urinary retention) still apply.
Glycopyrrolate inhaled prescription history
Animated chart of estimated U.S. prescriptions per year, Asthma/COPD meds (1924–2026). Glycopyrrolate inhaled enters in 2018 (estimated).
NO BOXED WARNINGS
Principal riskPeripheral anticholinergic effects; impaired sweating
Classes and tags
Clinical profile
Legacy pregnancy categoryUnknown / historical label unavailable
Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.
Open Glycopyrrolate inhaled in the interactive console ↗
Self-check
- Is inhaled glycopyrrolate a rescue treatment?
No—maintenance. - Which structural feature limits glycopyrrolate CNS entry?
Quaternary ammonium structure.